Summary
Church & Dwight Co., Inc. (CHD) filed its quarterly report on August 1, 2014, for the period ending June 30, 2014. The report details ongoing legal proceedings, emphasizing that while "in the ordinary course of its business," adverse outcomes could materially impact the company's financial health. Investors should note the company's active share repurchase programs, including two recent accelerated share repurchase (ASR) contracts totaling $435 million during the first half of 2014. These repurchases, funded by cash on hand, aim to reduce dilution from incentive plans and enhance shareholder value. The company also provided certifications from its CEO and CFO regarding the accuracy of the financial statements, as required by SEC rules, indicating a commitment to transparency and compliance.
Financial Highlights
54 data points| Revenue | $808.30M |
| Cost of Revenue | $451.90M |
| Gross Profit | $356.40M |
| R&D Expenses | $14.40M |
| SG&A Expenses | $104.80M |
| Operating Income | $138.20M |
| Interest Expense | $6.90M |
| Net Income | $88.80M |
| EPS (Basic) | $0.33 |
| EPS (Diluted) | $0.33 |
| Shares Outstanding (Basic) | 269.60M |
| Shares Outstanding (Diluted) | 274.60M |
Key Highlights
- 1Company is subject to various legal proceedings, with the potential for material adverse effects on its business, financial condition, and results of operations.
- 2Activated new share repurchase programs authorized in January 2014, with a total authorization of up to $500 million.
- 3Executed two Accelerated Share Repurchase (ASR) contracts totaling $435 million ($260 million and $175 million) during the first half of 2014.
- 4The ASR programs were funded using existing cash on hand.
- 5Initial deliveries of shares under ASR programs were received, with final settlements occurring later in 2014.
- 6Report includes certifications from CEO and CFO, affirming the accuracy of financial reporting under SEC regulations.
- 7XBRL data for financial statements (income, cash flows, balance sheets, etc.) for the relevant periods are available.